Dr. Narender Annapureddy, MD

Dr. Annapureddy practices at Nashville General Hospital in Nashville, Tennessee, part of Nashville General Hospital.

Dr. Annapureddy's NPI, 1821302597, was assigned on August 4, 2010. Dr. Annapureddy holds Tennessee license 51341.

Dr. Annapureddy's primary practice is Nashville General Hospital, at 1818 Albion Street, Nashville, TN 37208 in Davidson County. The practice phone is (615) 341-4490.

Dr. Annapureddy's primary practice is Nashville General Hospital in Nashville, Tennessee, part of Nashville General Hospital. Dr. Annapureddy is also affiliated with Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Annapureddy to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Annapureddy practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Annapureddy's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Annapureddy is licensed in Tennessee.

CMS data shows 565 Medicare services from Dr. Annapureddy across 4 procedure codes in 2024, for 202 Medicare patients. Medicare paid $25,420 for them.

CMS counts 202 Medicare patients who saw Dr. Annapureddy in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have arthritis, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Annapureddy's median patient age at 57, with 74% women.

In 2024, Dr. Annapureddy wrote 1,338 Medicare Part D claims for 183 patients. 71% of them were for generic drugs. CMS names the drug for 1,158 of them, across 27 drugs with 11 or more claims each, at $2,090,630 in total drug cost. In 2023, CMS named 1,000 claims across 25 drugs.

Dr. Annapureddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Annapureddy as offering telehealth.

Dmand AI links 44 papers to Dr. Annapureddy, published from 2012 to 2025. 2016 was the busiest year, with 6. The most frequent topics are Acute Kidney Injury, Renal Dialysis and Lupus Erythematosus, Systemic. Dr. Annapureddy has published most often in Lupus. Dr. Annapureddy's most frequent co-authors are Achint Patel, MD, Shiv Kumar Agarwal, MBBS, MD and Alexandre Miguel Benjo, MD.

Dmand AI links Dr. Annapureddy to 1 clinical trial. Conditions studied include Granulomatosis with Polyangiitis and Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.

CMS Open Payments shows 21 general payments to Dr. Annapureddy from 3 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 92% of the total. GlaxoSmithKline, LLC. paid the most, $16,585.